Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

Mostrar otras versiones (1)

Lithium and quetiapine are effective treatments for bipolar disorder, but their potential neuroprotective effects in humans remain unclear. A single blinded equivalence randomized controlled maintenance trial was conducted in a prospective cohort of first-episode mania (FEM) patients (n=26) to longi...

Descripción completa

Detalles Bibliográficos
Autores principales: Berk, M, Dandash, O, Daglas, R, Cotton, S M, Allott, K, Fornito, A, Suo, C, Klauser, P, Liberg, B, Henry, L, Macneil, C, Hasty, M, McGorry, P, Pantelis, Cs, Yücel, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545739/
https://www.ncbi.nlm.nih.gov/pubmed/28117843
http://dx.doi.org/10.1038/tp.2016.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545739/
https://www.ncbi.nlm.nih.gov/pubmed/28117843
http://dx.doi.org/10.1038/tp.2016.281

Ejemplares similares